Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EDAP Edap Tms	$1.47	$1.75	$1.26 ▼ $5.27	$54.96M	N/A	99,315 shs	101,923 shs
ICCM IceCure Medical	$1.03 +2.0%	$1.02	$0.48 ▼ $1.66	$60.46M	0.31	487,857 shs	280,178 shs
MLSS Milestone Scientific	$0.62 -3.9%	$0.85	$0.57 ▼ $1.39	$48.48M	0.8	118,570 shs	48,681 shs
PSTV Plus Therapeutics	$0.32 +2.2%	$0.35	$0.16 ▼ $2.31	$16.52M	0.69	10.62 million shs	3.83 million shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EDAP Edap Tms	-2.33%	-4.17%	-14.04%	+12.21%	-70.30%
ICCM IceCure Medical	-1.94%	-12.04%	+3.91%	-11.40%	+34.70%
MLSS Milestone Scientific	-1.08%	-2.93%	-26.93%	-28.95%	-33.31%
PSTV Plus Therapeutics	-5.74%	-4.86%	+0.96%	-52.81%	-82.68%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EDAP Edap Tms	3.0508 of 5 stars	3.2	5.0	2.7	1.7	0.6
ICCM IceCure Medical	2.317 of 5 stars	3.8	3.0	2.1	0.0	0.6
MLSS Milestone Scientific	2.9787 of 5 stars	3.5	5.0	1.9	2.5	0.0
PSTV Plus Therapeutics	1.6161 of 5 stars	3.3	2.0	2.2	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EDAP Edap Tms	2.33	Hold	$8.50	478.23% Upside
ICCM IceCure Medical	3.50	Strong Buy	$2.50	142.72% Upside
MLSS Milestone Scientific	3.00	Buy	$1.25	102.33% Upside
PSTV Plus Therapeutics	2.50	Moderate Buy	$10.83	3,243.62% Upside

Current Analyst Ratings Breakdown

Latest PSTV, EDAP, ICCM, and MLSS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/27/2025	PSTV Plus Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$5.50 ➝ $3.00
6/25/2025	PSTV Plus Therapeutics	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$9.00
6/5/2025	PSTV Plus Therapeutics	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $20.50
5/29/2025	ICCM IceCure Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$2.50
5/15/2025	EDAP Edap Tms	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral
5/5/2025	PSTV Plus Therapeutics	D Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
5/5/2025	PSTV Plus Therapeutics	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold
4/21/2025	PSTV Plus Therapeutics	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$19.00 ➝ $20.00

(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EDAP Edap Tms	$69.18M	0.79	N/A	N/A	$1.18 per share	1.25
ICCM IceCure Medical	$3.29M	18.38	N/A	N/A	$0.12 per share	8.58
MLSS Milestone Scientific	$8.61M	5.63	N/A	N/A	$0.11 per share	5.62
PSTV Plus Therapeutics	N/A	N/A	N/A	N/A	($1.52) per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EDAP Edap Tms	-$20.58M	-$0.62	N/A	N/A	N/A	-34.45%	-51.42%	-26.43%	8/27/2025 (Estimated)
ICCM IceCure Medical	-$15.32M	-$0.28	N/A	N/A	N/A	-467.37%	-182.26%	-112.65%	8/19/2025 (Estimated)
MLSS Milestone Scientific	-$6.93M	-$0.07	N/A	∞	N/A	-52.01%	-60.26%	-40.23%	N/A
PSTV Plus Therapeutics	-$12.98M	-$2.94	N/A	N/A	N/A	-520.90%	N/A	-202.73%	8/13/2025 (Estimated)

Latest PSTV, EDAP, ICCM, and MLSS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	PSTV Plus Therapeutics	-$0.12	N/A	N/A	N/A	$1.08 million	N/A
5/30/2025	Q1 2025	PSTV Plus Therapeutics	-$0.17	-$0.56	-$0.39	-$1.19	$1.11 million	$1.06 million
5/28/2025	Q1 2025	ICCM IceCure Medical	-$0.08	-$0.06	+$0.02	-$0.06	$0.75 million	$0.73 million
5/15/2025	Q1 2025	EDAP Edap Tms	-$0.16	-$0.20	-$0.04	-$0.20	$16.56 million	$16.37 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EDAP Edap Tms	N/A	N/A	N/A	N/A	N/A
ICCM IceCure Medical	N/A	N/A	N/A	N/A	N/A
MLSS Milestone Scientific	N/A	N/A	N/A	N/A	N/A
PSTV Plus Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EDAP Edap Tms	0.10	1.74	1.21
ICCM IceCure Medical	0.02	1.89	1.48
MLSS Milestone Scientific	N/A	2.85	1.86
PSTV Plus Therapeutics	N/A	1.03	1.03

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EDAP Edap Tms	62.74%
ICCM IceCure Medical	0.62%
MLSS Milestone Scientific	5.79%
PSTV Plus Therapeutics	3.28%

Insider Ownership

Company	Insider Ownership
EDAP Edap Tms	0.23%
ICCM IceCure Medical	2.44%
MLSS Milestone Scientific	24.75%
PSTV Plus Therapeutics	5.49%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EDAP Edap Tms	230	37.39 million	37.31 million	Optionable
ICCM IceCure Medical	60	58.70 million	57.27 million	Not Optionable
MLSS Milestone Scientific	30	78.48 million	58.61 million	Optionable
PSTV Plus Therapeutics	20	51.00 million	48.20 million	Not Optionable

PSTV, EDAP, ICCM, and MLSS Headlines

Recent News About These Companies

Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQ™ in Patients with Leptomeningeal Metastases

July 15 at 8:23 AM | finance.yahoo.com

Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQ™ in Patients with Leptomeningeal Metastases

July 15 at 7:30 AM | globenewswire.com

Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference

July 10, 2025 | globenewswire.com

Plus Therapeutics Initiates ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases Treatment

July 8, 2025 | quiverquant.comQ

Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases

July 8, 2025 | globenewswire.com

PSTV - Plus Therapeutics Inc Trailing Returns - Morningstar

July 2, 2025 | morningstar.comM

Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases

June 30, 2025 | globenewswire.com

Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary

June 26, 2025 | globenewswire.com

Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET

June 25, 2025 | globenewswire.com

Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer

June 25, 2025 | globenewswire.com

Plus Therapeutics Restructures Financing to Eliminate Potential Dilution of 1.5 Billion Shares

June 24, 2025 | quiverquant.comQ

Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing

June 24, 2025 | globenewswire.com

Plus (PSTV) Upgraded to Buy: Here's Why

June 19, 2025 | zacks.com

Plus Therapeutics Modifies Security Holders’ Rights

June 17, 2025 | tipranks.com

Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights

May 30, 2025 | finance.yahoo.com

Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates

May 30, 2025 | zacks.com

Plus Therapeutics, Inc. Reports Q1 2025 Financial Results and Updates on REYOBIQ™ Trials and CNSide® Assay Platform Progress

May 30, 2025 | quiverquant.comQ

Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights

May 30, 2025 | globenewswire.com

Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed ...

May 23, 2025 | gurufocus.com

Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

May 23, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PSTV, EDAP, ICCM, and MLSS Company Descriptions

Edap Tms NASDAQ:EDAP

$1.48 +0.01 (+0.34%)

As of 04:00 PM Eastern

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

IceCure Medical NASDAQ:ICCM

$1.03 +0.02 (+1.98%)

Closing price 04:00 PM Eastern

Extended Trading

$1.02 -0.01 (-0.87%)

As of 07:56 PM Eastern

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Milestone Scientific NYSE:MLSS

$0.62 -0.03 (-3.93%)

Closing price 04:00 PM Eastern

Extended Trading

$0.63 +0.01 (+1.49%)

As of 05:36 PM Eastern

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Plus Therapeutics NASDAQ:PSTV

$0.32 +0.01 (+2.21%)

Closing price 04:00 PM Eastern

Extended Trading

$0.33 +0.00 (+0.93%)

As of 07:59 PM Eastern

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time